Cardiac Surgery and the Human Immunodeficiency Virus

[1]  C. Sabin,et al.  Antiretroviral drugs and the risk of myocardial infarction - Reply , 2007 .

[2]  E. Cecchi,et al.  Infective Endocarditis in Intravenous Drug Users from Italy: the Increasing Importance in HIV-infected Patients , 2007, Infection.

[3]  O. Kirk,et al.  Class of antiretroviral drugs and the risk of myocardial infarction. , 2007, The New England journal of medicine.

[4]  H. Haddad,et al.  Cardiac transplantation in HIV-positive patients: are we there yet? , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  Richard D Moore,et al.  Incidence of, Risk Factors for, Clinical Presentation, and 1-Year Outcomes of Infective Endocarditis in an Urban HIV Cohort , 2006, Journal of acquired immune deficiency syndromes.

[6]  D. Adams,et al.  Excellent outcomes of cardiac surgery in patients infected with HIV in the current era. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Pomar,et al.  Cryopreserved mitral homograft in the tricuspid position for infective endocarditis: a valve that can be repaired in the long-term (13 years). , 2006, The Journal of heart valve disease.

[8]  J. Pillonel,et al.  Risque résiduel de transmission du VIH, du VHC et du VHB par transfusion sanguine entre 1992 et 2002 en France et impact du dépistage génomique viral , 2004 .

[9]  M. Oz,et al.  Should HIV-positive recipients undergo heart transplantation? , 2003, The Journal of thoracic and cardiovascular surgery.

[10]  F. Gharagozloo,et al.  Cardiac surgery in patients infected with the human immunodeficiency virus. , 2003, The Annals of thoracic surgery.

[11]  C. Hart,et al.  Infection control measures for adult cardiac surgery in the UK--a survey of current practice. , 2003, The Journal of hospital infection.

[12]  P. McCarthy,et al.  Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. , 2003, The New England journal of medicine.

[13]  J. Miro,et al.  Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1). , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  Kenichi A. Tanaka,et al.  Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). , 2003, Anesthesiology.

[15]  G. Barbarini,et al.  Incidence of the involvement of the cardiovascular system in HIV infection , 2003, AIDS.

[16]  P. Stock,et al.  Review of solid-organ transplantation in HIV-infected patients , 2003, Transplantation.

[17]  O. Kirk,et al.  Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study , 2003, HIV medicine.

[18]  H. Kawanishi,et al.  Type B lactic acidosis: a rare complication of antiretroviral therapy after cardiac surgery. , 2002, The Annals of thoracic surgery.

[19]  P. Ubel,et al.  Solid-organ transplantation in HIV-infected patients. , 2002, The New England journal of medicine.

[20]  H. Rollag,et al.  The above letter was sent Drs. Solheim, Rollag, and Svennevig, who offered the following reply. , 2000 .

[21]  R. Frater.  Cardiac surgery and the human immunodeficiency virus. , 2000, Seminars in thoracic and cardiovascular surgery.

[22]  E. Fosse,et al.  Viral safety of solvent/detergent‐treated plasma , 2000, Transfusion.

[23]  Everson,et al.  Significance of the human immunodeficiency virus infection in patients submitted to cardiac surgery. , 1999, The Journal of cardiovascular surgery.

[24]  R. Frater.  Human immunodeficiency virus and the cardiac surgeon: a survey of attitudesas originally published in 1989: updated in 1999 by , 1999 .

[25]  J. Fung,et al.  Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. , 1999, Blood.

[26]  P. Kissinger,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. , 1998, The New England journal of medicine.

[27]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[28]  D. Henderson.  Postexposure treatment of HIV--taking some risks for safety's sake. , 1997, The New England journal of medicine.

[29]  M. Wallack,et al.  Coronary Artery Bypass Grafting in Patients with Human Immunodeficiency Virus , 1997, Journal of cardiac surgery.

[30]  P. Heidenreich,et al.  Pericardial effusion in AIDS. Incidence and survival. , 1995, Circulation.

[31]  M. Corey,et al.  The HIV information project for transfusion recipients a decade after transfusion. , 1995, Archives of pediatrics & adolescent medicine.

[32]  Timothy J. Babinchak,et al.  Clinical Investigations: HIV/InfectionsPatients Treated by a Thoracic Surgeon With HIV: A Review , 1994 .

[33]  D. Vlahov,et al.  Temporal association between implementation of universal precautions and a sustained, progressive decrease in percutaneous exposures to blood. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  David P Lisbon.  Cardiac tamponade in patients infected with HIV: A report from an Inner-city Hospital , 1994 .

[35]  J. Pomar,et al.  Cardiopulmonary bypass in HIV-positive patients. , 1993, The Annals of thoracic surgery.

[36]  M. Turina,et al.  Endocarditis in intravenous drug addicts and HIV infected patients: possibilities and limitations of surgical treatment. , 1993, The Journal of heart valve disease.

[37]  A. Holladay,et al.  Cardiac malignant lymphoma in acquired immune deficiency syndrome , 1992, Cancer.

[38]  C Santoli,et al.  Cardiac Surgery in HIV-positive Intravenous Drug Addicts: Influence of Cardiopulmonary Bypass on the Progression to AIDS , 1992, The Thoracic and cardiovascular surgeon.

[39]  A. Muñoz,et al.  Transmission of Retroviruses from Seronegative Donors by Transfusion during Cardiac Surgery , 1992, Annals of Internal Medicine.

[40]  H. Fineberg,et al.  How Safe Is Safe Enough? New Infections and the U.S. Blood Supply , 1992, Annals of Internal Medicine.

[41]  A. Carpentier,et al.  Cardiac Surgery in Patients with Human Immunodeficiency Virus Infection: Indications and Results , 1992, Journal of cardiac surgery.

[42]  K. Phelps,et al.  Rapid evolution of cardiac tamponade due to bacterial pericarditis in two patients with HIV-1 infection. , 1992, Chest.

[43]  M P Weinstein,et al.  Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. , 1990, The Journal of infectious diseases.

[44]  T E Starzl,et al.  Transplantation in HIV+ patients. , 1990, Transplantation.

[45]  K. Ramaiya,et al.  Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania , 1990, The Lancet.

[46]  C. Good,et al.  Pericardial effusion and tamponade due to Kaposi's sarcoma in acquired immunodeficiency syndrome. , 1989, Chest.

[47]  B. Polk,et al.  Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery , 1989, The New England journal of medicine.

[48]  R. Holzman,et al.  Cryptococcal pericarditis in an intravenous drug abuser. , 1985, The Journal of infectious diseases.

[49]  R. Kapila,et al.  Actinomycetales infection in the acquired immunodeficiency syndrome. , 1985, Annals of internal medicine.

[50]  Rodolphe Thiébaut,et al.  Combination antiretroviral therapy and the risk of myocardial infarction , 2003 .

[51]  J. Tanner,et al.  Double gloving to reduce surgical cross-infection. , 2002, The Cochrane database of systematic reviews.

[52]  C. Abad,et al.  Cardiac surgery in patients infected with human immunodeficiency virus. , 2000, Texas Heart Institute journal.

[53]  R. Frater.  As originally published in 1989: human immunodeficiency virus and the cardiac surgeon: a survey of attitudes. Updated in 1999. , 1999, The Annals of thoracic surgery.

[54]  I. Touw,et al.  Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. , 1999, Blood.

[55]  E. Klatt.  Surgery and human immunodeficiency virus infection: indications, pathologic findings, risks, and risk prevention. , 1994, International surgery.

[56]  N. Wiinberg,et al.  Accidental injuries and blood exposure to cardiothoracic surgical teams. , 1992, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[57]  R. Frater,et al.  Cardiac surgery in human immunodeficiency virus (HIV) carriers. , 1989, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.